The FDA just approved tirzepatide for type 2 diabe
Post# of 148181
(Total Views: 743)
Posted On: 05/17/2022 2:01:34 AM
The FDA just approved tirzepatide for type 2 diabetes. It is a GIP/GLP-1 agonist (activator). CCL5 (RANTES) downregulates GLP-1 and of course CCR5 blockade by leronlimab would upregulate it. It would be brilliant if current management ever did anything about it.
https://citeseerx.ist.psu.edu/viewdoc/downloa...p;type=pdf
https://citeseerx.ist.psu.edu/viewdoc/downloa...p;type=pdf
(15)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼